Browsing: Disease Area > Bacterial
Ahead of the Call to Action on Antimicrobial Resistance in Berlin the UK’s Chief Medical Officer, Sally Davies, spoke about the need to ensure antimicrobial resistance stays on the political agenda, and the role of the individual in achieving this, at Antibiotic Research UK’s annual lecture.
Silver nanoparticles have long been used as potent antibacterial agents. However, toxicity concerns of silver nanoparticles have limited their successful clinical applications. This research reports a simple and cost-effective method for the synthesis of nickel-prussian blue@silver nanocomposites.
Researchers have reported that statins could have an antimicrobial effect against Staphylococcus aureus – indicating that statin users may have a decreased risk of S. aureus bloodstream infections outside of hospitals.
In this editorial the authors discuss the current methods for identifying carbapenemase producers and give a future perspective, highlighting the imemdiate action required to tackle the broader problem of antimicrobial resistance.
Julie Kaiser discusses the findings and implications of a recent study published in PNAS modeling the sequence of events that increases the risk of colonization and infection with multidrug-resistant (MDR) bacteria.
Blood infection (sepsis) causes millions of deaths worldwide and is the most frequent cause of death in hospitalized patients. Sepsis…
Researchers have discovered that a leaderless intercellular peptide signal may contribute to group A Streptococcus virulence; providing a framework for the identification in other microorganisms that may potentially serve as therapeutic targets.